stockrowNiagen Bioscience, Inc.
NAGE Consumer Defensive Packaged Foods
Niagen Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.4 million, up 29.9% from fiscal 2024.
- Revenue
- −20.0%
- EPS
- −124.7%
- Free cash flow
- −28.4%
Quarter to September 2026, against a year earlier
Follow NAGE
Alert me
Niagen Bioscience, Inc. (NAGE) EV/Sales
As of 6 November 2026, Niagen Bioscience, Inc. (NAGE) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from 0.8× (November 2026) to 20.1× (November 2017) — the current reading is the lowest in ten years. That is below the Packaged Foods industry median of 0.9× and below the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.4× | (5.91%) |
| FY2024 | 3.6× | 269.76% |
| FY2023 | 1.0× | (28.99%) |
| FY2022 | 1.4× | (59.42%) |
| FY2021 | 3.4× | (27.69%) |
| FY2020 | 4.7× | (5.05%) |
| FY2019 | 4.9× | (7.11%) |
| FY2018 | 5.3× | (52.95%) |
| FY2017 | 11.3× | 89.77% |
| FY2016 | 6.0× | (18.61%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.3× | (8.29%) |
| Jun 2026 | 1.5× | (33.93%) |
| Mar 2026 | 2.2× | (35.20%) |
| Dec 2025 | 3.4× | (37.74%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| WYHG Wing Yip Food Holdings Group Limited - Sponsored ADR compare | n/m |
| USNA USANA Health Sciences, Inc. compare | 0.2× |
| NATR Nature's Sunshine Products, Inc. compare | 0.2× |
| BRCC BRC Inc. compare | 0.3× |
| NAGE Niagen Bioscience, Inc. | 0.8× |
| OTLY Oatly Group AB Sponsored ADR compare | 0.8× |
| BGS B&G Foods, Inc. compare | 1.2× |
| BYND Beyond Meat, Inc. compare | 1.2× |
| PRE Prenetics Global Limited compare | 1.4× |
| Packaged Foods industry median | 0.9× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)